Company Filing History:
Years Active: 2019-2024
Title: James B Trager: Innovator in Cancer Treatment
Introduction
James B Trager is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Trager's work focuses on improving patient outcomes in cancer therapies.
Latest Patents
Trager's latest patents include groundbreaking research on gene expression markers for predicting overall survival in subjects treated with sipuleucel-T. This patent outlines a method that involves determining gene expression levels of specific biomarkers to create a score that predicts overall survival probabilities. Another significant patent addresses the humoral immune response against tumor antigens following treatment with cancer antigen-specific active immunotherapy. This work provides compositions and methods for predicting therapeutic outcomes by measuring patient responses using predetermined biomarkers.
Career Highlights
Throughout his career, Trager has worked with prominent companies in the biotechnology sector, including Dendreon Corporation and Dendreon Pharmaceuticals LLC. His experience in these organizations has allowed him to contribute to the development of innovative cancer therapies.
Collaborations
Trager has collaborated with notable professionals in the field, including Nadeem Sheikh and Debraj GuhaThakurta. These collaborations have further enhanced his research and development efforts in cancer treatment.
Conclusion
James B Trager's contributions to cancer treatment through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative work continues to influence the field of oncology.